PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9658482

[Partial complex status epilepticus: diagnostic difficulties].

J Vaquerizo·J C Romero-Rodríguez·A González-Roncero·A Gómez-Marcos
View original source ↗Export metadata ↓

Abstract

INTRODUCTION AND CLINICAL CASE: We present a case of complex partial non convulsive status epilepticus which we think it is very interesting because it caused a challenged diagnostic. The patient, a male of eleven years old had affective symptoms in episodes. They occurred lasted six to eight hours, once or twice a month. The seizures began after a stressfully psychology experience. Currently and after of some months of follow-up, the patient is free of symptoms and he receives a treatment with valproate acid and vigabatrin. CONCLUSION: We also discuss possible precipitating factors, differential diagnosis and prognosis.

Explore related subjects

AnticonvulsantsChildCrimeDiagnosis, DifferentialDrug Therapy, CombinationElectroencephalographyEpilepsy, Complex PartialHumansMaleMood DisordersStatus EpilepticusStress Disorders, Post-TraumaticStress, PsychologicalValproic AcidVigabatringamma-Aminobutyric AcidCase ReportsEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Vaquerizo, J C Romero-Rodríguez, A González-Roncero, A Gómez-Marcos. 1998. [Partial complex status epilepticus: diagnostic difficulties].. https://pubmed.ncbi.nlm.nih.gov/9658482/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

The effect of egg albumin on the crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets and in aqueous solutions.

The influence of egg albumin (EA) on the crystal habit properties of carbamazepine (CBZ) in aqueous solutions, solid-state, and in sustained release matrix tablets was investigated using differential scanning calorimetry (DSC), hot-stage microscopy (HSM), X-ray powder diffraction (XRD), scanning electron microscopy (SEM) and contact angle goniometer (CAG). The results suggest that in solid-state mixtures, EA affected the polymorphic transitions of CBZ from the beta to the alpha form. In hydrated matrix tablets and aqueous solutions, EA influenced the conversion rate of CBZ to the dihydrate form depending on EA concentration. It was found that increasing EA concentration enhanced CBZ dihydrate aggregation, an effect that leads to the formation of crystals with high mechanical strength and decrease of CBZ solubility. Possible mechanisms, which explain crystal growth and aggregation, as well as alteration of CBZ polymorphic transitions in the solid-state, gel layer, and in aqueous solution were suggested. In the gel layer of hydrated tablets the kinetics of CBZ transformation to the dihydrate form, crystal growth and aggregation were influenced by various processes: matrix hydration, erosion mechanism and the formation of metastable conditions, which favor aggregation and growth. The release kinetics of CBZ from the matrix highly correlated with the crystalline and morphological changes occurring in the matrix.

Anticonvulsants↗
PubMed2000

Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB.

Sodium valproate (VPA) is frequently used to treat epilepsy and convulsive disorders. Several reports have indicated that anti-epileptic drugs (AED) affect the immune system, but the mechanism has not been clear. We examined whether the commonly used AEDs, diazepam (DZP), carbamazepine (CBZ), phenobarbital (PB), phenytoin (PHT), and VPA, can inhibit activation of the nuclear transcription factor kappa B (NF-kappaB), in human monocytic leukemia cells (THP-1) and in human glioma cells (A-172). NF-kappaB is essential to the expression of the kappa light chain of immunoglobulin and proinflammatory cytokines. Electrophoretic mobility shift assays (EMSA) of nuclear extracts demonstrated that VPA inhibits NF-kappaB activation induced by lipopolysaccharide (LPS), but the other AEDs do not. Western blot analysis revealed that this inhibition is not linked to preservation of expression of IkappaBalpha protein. Chloramphenicol acetyltransferase (CAT) assay indicated that NF-kappaB-dependent reporter gene expression is suppressed in glioma cells pretreated with VPA. VPA significantly inhibited LPS-induced production of TNF-alpha and IL-6 by THP-1 cells, whereas other AEDs did not. The findings are consistent with the idea that VPA suppresses TNF-alpha and IL-6 production via inhibition of NF-kappaB activation. Our results suggest that VPA can modulate immune responses in vitro. These findings raise the possibility that such modulation might occur with clinical use of VPA.

Anticonvulsants↗